U.S. flag

An official website of the United States government

NC_000012.11:g.80632665_80732812del AND Rare genetic deafness

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 27, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000826218.4

Allele description [Variation Report for NC_000012.11:g.80632665_80732812del]

NC_000012.11:g.80632665_80732812del

Gene:
OTOGL:otogelin like [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
12q21.31
Genomic location:
Chr12: 80632665 - 80732812 (on Assembly GRCh37)
Preferred name:
NC_000012.11:g.80632665_80732812del
HGVS:
  • NC_000012.11:g.80632665_80732812del
  • NM_173591.3:c.825_4834-43del
  • p.?
Observations:
1

Condition(s)

Name:
Rare genetic deafness
Identifiers:
MedGen: C5680250; Orphanet: 96210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000967790Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Likely pathogenic
(Feb 27, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown11not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000967790.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The deletion of exons 9-41 (of 58 total exons) in the OTOGL gene has not been previously reported in individuals with hearing loss, but has been reported in four different studies in the Database of Genomic Variants with the highest frequency of 2/1109 samples (http://dgv.tcag.ca; Variants dgv1530n100, esv2761110, esv3580340, and esv3580340). Similar deletions have also been reported in ClinVar (Variation IDs 601318, 613849,396434). This deletion encompasses a substantial proportion of the coding region of the OTOGL gene and likely results in a truncated or absent protein. Loss of function of the OTOGL gene is an established disease mechanism for autosomal recessive hearing loss. Breakpoints of the deletion were observed in the NGS read data. In summary, this variant is likely pathogenic for recessive sensorineural hearing loss based on its predicted impact to the protein. ACMG/AMP criteria applied: PVS1, PM2_Supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not provided1not provided

Last Updated: Apr 7, 2025